OrthoPediatrics Corp. Completes First Procedures with VerteGlide™ Spinal Growth Guidance System
OrthoPediatrics (NASDAQ: KIDS) has successfully completed the first U.S. surgical procedures using its VerteGlide Spinal Growth Guidance System, a breakthrough treatment for Early Onset Scoliosis (EOS). The procedures were performed by Dr. Richard McCarthy and Dr. Kent Walker in Louisville, Kentucky.
The VerteGlide system, part of OrthoPediatrics' Scoliosis product suite, represents an innovative solution for complex spinal pathology in early onset scoliosis patients. The technology, which utilizes Shilla™ technology licensed from Medtronic, will be featured at the 60th Annual Meeting of the Scoliosis Research Society and the 19th International Congress on Early Onset Scoliosis later this year.
OrthoPediatrics (NASDAQ: KIDS) ha portato a termine con successo i primi interventi chirurgici negli Stati Uniti impiegando il suo VerteGlide Spinal Growth Guidance System, una soluzione innovativa per il trattamento della scoliosi ad esordio precoce (EOS). Le procedure sono state eseguite dal Dr. Richard McCarthy e dal Dr. Kent Walker a Louisville, Kentucky.
Il sistema VerteGlide, parte della linea di prodotti per la scoliosi di OrthoPediatrics, rappresenta un approccio avanzato per patologie spinali complesse nei pazienti con EOS. La tecnologia, che incorpora la Shilla™ technology concessa in licenza da Medtronic, sarà presentata al 60th Annual Meeting of the Scoliosis Research Society e al 19th International Congress on Early Onset Scoliosis nel corso di quest'anno.
OrthoPediatrics (NASDAQ: KIDS) ha completado con éxito los primeros procedimientos quirúrgicos en EE. UU. utilizando su VerteGlide Spinal Growth Guidance System, un avance en el tratamiento de la escoliosis de inicio temprano (EOS). Los procedimientos fueron realizados por el Dr. Richard McCarthy y el Dr. Kent Walker en Louisville, Kentucky.
El sistema VerteGlide, que forma parte de la línea de productos para escoliosis de OrthoPediatrics, ofrece una solución innovadora para la patología espinal compleja en pacientes con EOS. La tecnología, que incorpora la Shilla™ technology con licencia de Medtronic, se presentará en el 60th Annual Meeting of the Scoliosis Research Society y en el 19th International Congress on Early Onset Scoliosis a finales de este año.
OrthoPediatrics (NASDAQ: KIDS)는 VerteGlide Spinal Growth Guidance System을 이용한 미국 내 첫 수술을 성공적으로 마쳤습니다. 이는 조기 발병 척추측만증(EOS) 치료에 있어 획기적인 진전입니다. 해당 수술은 루이스빌(켄터키)에서 Dr. Richard McCarthy와 Dr. Kent Walker가 집도했습니다.
VerteGlide 시스템은 OrthoPediatrics의 척추측만증 제품군에 속하며, EOS 환자의 복잡한 척추 병변에 대한 혁신적 해결책을 제시합니다. Medtronic으로부터 라이선스 받은 Shilla™ technology를 적용한 이 기술은 올해 열리는 60th Annual Meeting of the Scoliosis Research Society와 19th International Congress on Early Onset Scoliosis에서 공개될 예정입니다.
OrthoPediatrics (NASDAQ: KIDS) a mené avec succès les premières interventions chirurgicales aux États-Unis utilisant son VerteGlide Spinal Growth Guidance System, une avancée dans le traitement de la scoliose à début précoce (EOS). Les interventions ont été réalisées par le Dr Richard McCarthy et le Dr Kent Walker à Louisville, dans le Kentucky.
Le système VerteGlide, qui fait partie de la gamme de produits pour la scoliose d'OrthoPediatrics, constitue une solution innovante pour les pathologies complexes de la colonne vertébrale chez les patients atteints d'EOS. Cette technologie, qui utilise la Shilla™ technology sous licence de Medtronic, sera présentée lors du 60th Annual Meeting of the Scoliosis Research Society et du 19th International Congress on Early Onset Scoliosis plus tard cette année.
OrthoPediatrics (NASDAQ: KIDS) hat erfolgreich die ersten chirurgischen Eingriffe in den USA mit seinem VerteGlide Spinal Growth Guidance System durchgeführt – eine bahnbrechende Behandlungsoption für Early Onset Scoliosis (EOS). Die Eingriffe wurden von Dr. Richard McCarthy und Dr. Kent Walker in Louisville, Kentucky, vorgenommen.
Das VerteGlide-System, Teil der Skoliose-Produktreihe von OrthoPediatrics, stellt eine innovative Lösung für komplexe Wirbelsäulenpathologien bei EOS-Patienten dar. Die Technologie, die die von Medtronic lizenzierte Shilla™ technology nutzt, wird im Laufe des Jahres auf dem 60th Annual Meeting of the Scoliosis Research Society und dem 19th International Congress on Early Onset Scoliosis vorgestellt.
- Successful completion of first U.S. surgical procedures with VerteGlide system
- Addresses significant unmet clinical need in Early Onset Scoliosis treatment
- Technology licensed from industry leader Medtronic
- Strong endorsement from leading pediatric orthopedic surgeon
- None.
Insights
OrthoPediatrics launches breakthrough VerteGlide system for Early Onset Scoliosis, expanding their treatment portfolio with innovative technology addressing unmet pediatric needs.
OrthoPediatrics has successfully completed the first U.S. procedures using their VerteGlide Spinal Growth Guidance System for treating Early Onset Scoliosis (EOS) - a significant milestone for their pediatric orthopedics portfolio. This system represents a technological advancement in addressing complex spinal pathology in young patients where treatment options are extremely limited.
The clinical significance of this launch cannot be overstated. EOS affects children typically under 10 years old and presents unique challenges as the spine continues growing. Traditional scoliosis treatment approaches often involve either observation (potentially allowing progression) or fusion surgeries (which halt growth). Growth-friendly technologies like VerteGlide provide a critical middle option that can correct deformity while allowing continued spinal development.
This system employs the Shilla™ technology licensed from Medtronic, suggesting a partnership arrangement that enables OrthoPediatrics to leverage established intellectual property while applying their pediatric-specific expertise. The endorsement from Dr. McCarthy, a respected pediatric orthopedic surgeon who performed one of the inaugural procedures, provides clinical validation crucial for adoption in the specialized pediatric orthopedic community.
VerteGlide's upcoming features at the Scoliosis Research Society Annual Meeting and the International Congress on Early Onset Scoliosis represent strategic marketing opportunities to build awareness among the precise specialist surgeon audience that would utilize this technology. These are the two most significant gatherings for pediatric spine surgeons who treat scoliosis, making them ideal venues for showcasing new treatment options.
By focusing on complex EOS cases, OrthoPediatrics continues to demonstrate their commitment to addressing the most challenging pediatric orthopedic conditions, further cementing their unique market position as the only company exclusively dedicated to pediatric orthopedics.
WARSAW, Ind., Sept. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the completion of the first U.S. surgical procedures with the VerteGlide Spinal Growth Guidance System (“VerteGlide”), used to treat Early Onset Scoliosis (“EOS”).
Dr. Richard McCarthy, a pediatric orthopedic spine surgeon in Louisville, Kentucky who, along with Dr. Kent Walker, performed one of the first procedures shared, “The first procedures with VerteGlide were a great success. For these patients, there is a very limited set of options, and this breakthrough growth guidance system offers a solution for a significant unmet clinical need. This technology will greatly benefit the first patients and many other kids in the future. OrthoPediatrics should feel very proud of the work put into creating this device for the benefit of children”.
As part of OrthoPediatrics’ Scoliosis suite of products, VerteGlide provides another unique alternative for the treatment of scoliosis that leverages advanced implant and instrument technology. VerteGlide is a unique Scoliosis deformity correction system for early onset scoliosis patients that exhibit some of the most complex spinal pathology. In addition, VerteGlide will be featured at the upcoming 60th Annual Meeting of the Scoliosis Research Society in September, and the 19th International Congress on Early Onset Scoliosis meeting in November.
OrthoPediatrics Scoliosis division President, Greg Odle commented, “By leveraging the knowledge of a first-class surgeon design team that has the most practical knowledge of pediatric spinal growth guidance concepts, this system offers surgeons a unique ability to treat EOS by addressing the most diseased areas of the spinal column. The complex nature of EOS demands that surgeons have access to the most cutting-edge technology available. We are pleased to offer the most advanced system on the market and to see the success of the first procedures.”
The VerteGlide Spinal Growth Guidance System is made possible with the Shilla™ technology licensed from Medtronic.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937- 5406
FAQ
What is OrthoPediatrics' VerteGlide Spinal Growth Guidance System?
Who performed the first VerteGlide procedures for KIDS stock?
When will OrthoPediatrics (KIDS) showcase the VerteGlide system?
What technology partnership does OrthoPediatrics have for VerteGlide?
What clinical need does the KIDS VerteGlide system address?
